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Abstract: Neurological disorders cause a number of both mood and motivation problems, as well neuropsychological 
deficits. Apathy is a major clinical sequelea seen after stroke. Patients with stroke patients have features of depression, 
and motivation impairment (apathy). Apathy is a reduction in initiating cognitive, emotional and behavioural responses. 
Patients have lower motivation in many psychological domains. Therefore, apathy is proposed here as “negative 
symptom” of stroke. Apathy is a prevalent clinical presentation and causes problems to caregiver and rehab teams. The 
pathophysiology and neuroanatomy is not specific but detectable. It needs a special approach in understanding as well 
as treatment and rehabilitation. Apathy is a good predictor of outcome in rehabilitation. The treatment is a 
multidisciplinary and needs deferent management from depression. Here we raise clinical awareness and encourage 
Clinicians and researchers address apathy as it has significant recovery impact.  
Keywords: Stroke, Brain disease, Apathy, Depression, Rehab, Neuropsychology. 
INTRODUCTION 
Neuropsychological disorders, as well as mood and 
motivation disorders are common consequences of 
brain disease and injuries. This includes both traumatic 
(such as TBI) as well as non-traumatic injury, .e.g. 
stroke, and tumour [1, 2]. 
It has been widely accepted now that stroke is a 
major public health problem in the USA, and globally; 
every year about 795 000 people in the USA alone 
have a stroke [3]. Of the 15-millions people worldwide 
who suffer a stroke annually, at least 5 million are 
permanently disabled, placing a burden on family and 
community [1, 3]. Depression and apathy are very 
common features of post stroke clinical presentations 
[1, 2]. Apathy is an important clinical problem effects 
the outcome of treatment and rehab [4]. Apathy is both 
common symptoms and ignored clinical problem of 
chronic neurological diseases [2]. This paper will 
address the problem of apathy in relation to mainly 
stroke, but other neurological disorders are also 
indicated. The aim is to explain the symptoms and its 
relations to other clinical manifestations following 
stroke.  
Apathy can be seen in many disorders, such as TBI, 
CVA, AD, Parkinson’s disease [2, 5]. Therefore, there 
is no specificity of apathy related to a given brain 
disorder. It can be argued, therefore, that apathy is a 
symptom, not a syndrome, related to a number of brain 
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disorders. While other researchers suggest that apathy 
is a syndrome post stroke [1].  
Apathy 
Apathy has been linked to brain disease from the 
ancient Greek times, the word pathos or passions [7], 
therefore apathy means lack of interest and lower 
motivation. Apathy is not attributed to a diminished 
level of consciousness, cognitive impairment or 
emotional distress, but impaired motivation [8]. But the 
concept “boul” means will and aboulia means lack of a 
will, in Greek. When patients show physiological and 
psychological non-reactivity [9] they are considered to 
have apathy. Behavioural approaches consider 
operational definition and classification [9] suggest that 
apathy is “characterised by diminished goal-directed 
behaviour, diminished goal-directed cognition, and 
decreased emotional concomitants of goal directed 
behaviour”. It is interesting to see here inclusive 
definition, to account for behaviour, cognition and 
emotion. The salient point here of course is the 
‘decreased’ level of output. 
But another domain that seems to be missing in 
definition and discussions is the lack of awareness. 
This may also be included in both definition and 
assessments. Patients with neurological diseases show 
impaired cognitive, emotional as well as behavioural 
goal-directed behavior [1]. Cognitively, they show 
impaired interest in attending or learning new skills. 
Emotionally, when they are not showing responses of 
emotional nature to environments around them. 
Behaviourally, for instance, they show deficits in action 
in response to stimuli; either targeting them or relevant 
to the daily activities. Though others [10] have 
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considered it as a motivation deficits, there is 
inconsistency among researchers and clinicians as to 
the definition yet. 
Clearly some researchers think that apathy as “the 
absence of feeling that frequently occurs together with 
a lack of emotional sensitivity and flattening of affective 
response” [9]. From a behavioural perspective, apathy 
defined as “a behavioural syndrome consisting of a 
reduction of self-generated voluntary and purposeful 
behavioural” [9], with a weakness in labelling it 
“syndrome” since it is not independent of neurological 
disorders. Clinically, we see patients with deficits in 
spontaneity of action and reduced initiation too. Hence, 
motivation is a key feature of the disorder and 
considered in recent definition including, the emotional, 
cognitive and behavioural domains [11]. Robert et al 
[6], assert that apathy is a disorder of motivation, but 
failed to mention the lower output of motivation. 
Apathy as such is a diminished motivational output 
of patients (in many domains –cognitive, behavioural 
and emotional), that effects their daily activities, quality 
of life and so on [5, 6], while no physical disability can 
be accounted for apathy. 
Apathy is “Negative Symptoms” of Stroke 
All the above suggests that the main feature of 
apathy is reduction or diminished behavioural output 
from patients with neurological disease or disorders, 
such as stroke, AD, or TBI among others. When we 
look closely at the clinical presentation of apathy 
among patients with neurological disorders [1, 2] and 
examine the assessments tools and questions, it 
clearly circle around the ‘output’, rather than the ability. 
Patients show limited or absent output on a number of 
behavioural, psychological functioning post illness. 
Therefore, we propose here to consider ‘apathy’ as 
“negative symptoms” following CVA. Other neurological 
disorders may also cause such abnormality. This short 
paper attempts to delineate its “negativeness” in a 
clinical sense, and invite clinicians to consider it as 
such. This will, it is hoped, help to encourage different 
approaches in labelling as well as treating. This is in 
contrast to “positive symptoms” following CVA. Post 
stroke patients may show positive symptoms such as 
hemiplegia, dysphagia, anxiety, anger, irritability and 
depression as emotion. The positive symptoms 
represent ‘increased’ output, while “negative 
symptoms” show ‘decreased’ output. Here is the 
proposed difference. 
Therefore, apathy needs to be considered as an 
independent specific clinical presentation with possible 
different not-yet known pathogeneses and that it 
requires a specific treatment approaches. 
Classification of Apathy 
Apathy has not been well addressed [1] and its 
classification was ignored. No mentioning was there of 
the term apathy in the International Classification of 
Diseases (ICD) -10 [12]. The DSM 5 has improved on 
the previous version, and included apathy on certain 
disorders apathetic type” is listed as one subtype of 
“personality change due to a general medical  
condition” [13]. 
While there is no an accepted definition of apathy, 
there are attempts of classification. Some proposed 
three criteria for diagnoses and classifications: (I) 
decreased spontaneity in activity and speech; (ii) 
prolonged latency in responding to queries, directions 
and other stimuli; and (iii) reduced ability to persist with 
a task” [see 14, 1]. 
Clinical presentations show that there are many 
types and degrees of apathy [1, 2]. Any valid and 
comprehensive classification has to stem from a valid, 
reliable definition and comprehensive list of all 
manifestations. Particularly, it is important that 
classification to show the “negative” (i.e. reduced) 
features of its clinical presentation, as clinical negative 
symptoms of stroke (or other neurological diseases). 
Apathy and Depression 
Apathy and depression are partially overlapping 
clinical presentations as well as concepts. They share 
symptoms such as diminished interest in activities and 
psychomotor retardation. However, cognitive and 
affective symptoms of depression, such as feelings of 
worthlessness or guilt and anhedonia [see; 1, 2, 15], 
are not considered a part of apathy. Apathy can be 
correlated with items of depression scales, but not with 
euphoric items [16]. Patients with Parkinson disease, 
for instance, can show apathy but not depression, while 
vascular disorder can show depression with no  
apathy [17]. 
Studies have also supported a distinction between 
anhedonia, defined as loss of interest or pleasure, and 
apathy. In a study using the Beck Depression Inventory 
and Apathy Scale with Parkinson’s disease patients, 
the best fitting symptom model included separate 
apathy and anhedonia factors [18]. This finding was 
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replicated in a study using multiple measures of 
anhedonia and a measure of apathy that includes 
scales for the three proposed symptom dimensions 
(the Lille Apathy Rating Scale) [19]. 
In both of these studies, a reduction in interest or 
pleasure was distinct from behavioural symptoms of 
apathy (e.g., reduced motivation and engagement in 
activities). 
In both anhedonia and depression the fact that 
there is loss of pleasure (subjective experience) is a 
distinctive feature from a behavioural deficit in 
engaging in activities or initiating them [2]. 
It seems that apathy can be independent, but can 
be mixed with, depression and anhedonia. Such 
independence warrants of course an independent 
clinical consideration as well as research approach. 
Multiple studies support further the distinction 
between the two constructs. For example, one study 
found that the best fitting model in a confirmatory factor 
analysis of an apathy and depression symptoms was 
one which included multiple factors, including separate 
apathy and dysphoric mood factors [18]. In evaluating 
both, scales may have similar items and that may 
present an invalid similarities. But the distinction 
between apathy and depression is more apparent 
when informant reported vs. self-reported ratings are 
used. For example, in a sample of 49 patients with 
brain damage, self-rated apathy was significantly 
correlated with clinician-rated depression (r = 0.48, 
p<.05), but informant-rated apathy was not (r = 0.15, 
p>.05) [20]. Similar results were found in a relatively 
large mixed neurological and healthy elderly 
comparison sample (n=107) in which a clinician-rated 
measure of depression excluding apathy symptoms 
was used [21]. Though the two studies differ in sample 
number and aetiologies, but they show similarities. 
Apathy and depression differ in their ability to 
predict conversion to dementia in individuals with mild 
cognitive impairment [22].  
Several studies have shown that apathy has 
stronger associations with cognitive and functional 
impairment than depression [23, 24]. 
Naturally, the distinction between apathy and 
depression has clinical and treatment implications. 
Apathy is associated with impaired insight about one’s 
illness and cognitive abilities while depression is 
associated with greater insight [1, 25].  
Apathy and depression have different structural and 
functional neural correlates [26, 27]. Apathy is 
associated with lesions to frontal lobe, subcortical 
areas for instance, but not depression [2, 28, 29]. This 
also explains in part the variety of apathy (present or 
absent) among patients with neurological disorders. 
Research on localization of brain areas associated 
with depression in post stroke was controversial, but 
certain studies found left anterior to be associated [see 
for a review, [30].  
It is worth noting, however, that apathy and 
depression can occur as comorbidity. It is estimated 
that nearly have of patients with depression can have 
apathy, but much less of the apathy patients report 
depression [1, 2] post stroke. 
Apathy Post Stroke 
There is significant literature about apathy in 
different brain diseases. It can be followed after 
Parkinson’s disease [5] ; dementia and AD (6; see 
above). Here we will consider apathy following CVA. 
Not surprisingly, literature also examined apathy 
following stroke. One study found that a significant 
number (23%) of patients with stroke had a significant 
degree of apathy. The apathetic patients were 
characterized by being older, having a higher 
frequency of major but not minor depression, having a 
greater degree of physical and cognitive impairment, 
and having lesions involving the posterior limb of the 
internal capsule [9, 10]. 
Andersson et al. Anderson also examined apathy in 
patients with stroke (n =30), traumatic brain injury (n 
=27), and hypoxic brain injury (n =13). Apathy was 
associated with subcortical right hemisphere lesions as 
well as a decreased score on the active approach 
oriented coping questionnaire [32]. Patients naturally 
after CVA show cognitive impairments, at least some of 
them. But the focus here on the apathy as well as 
certain cognitive impairments. Ghika-Schmid and 
Bogousslavsky [33] examined 12 CVA patients with 
anterior thalamic infarcts. Although the acute period 
was characterized by perseverative behaviour and 
anterograde memory retrieval deficit as well as 
intrusions, naming difficulties and dysarthria within a 
few months follow-up, the persisting abnormalities 
included memory dysfunction and apathy. This report 
as well as other anecdotal reports in the literature 
suggested that apathy following stroke, particularly 
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associated with bilateral lesions, and may persist for 
many years. Another study [2, 28, 29, 34] reported on a 
patient (20 Left Frontal Thalamus, 40 Basal ganglia, 60 
Internal capsule); 80% of patients show effect of 
apathy. 
The only lesion location that was significantly more 
frequent in patients with apathy compared to the other 
groups was the posterior arm of the internal capsule. 
This may reflect the interruption of pallidomesen- 
cephalic fibres from the inner pallidum to the 
pedunculopontine nucleus which in cats and rodents 
plays an important role in goal-oriented 
Locomotion (data from 9) with right intralaminar 
nuclei infarction of the thalamus with apathy and 
cognitive deficits persisting for more than 17 years  
[28, 29].  
Lesions studies that have been conducted suggest 
that lesions of many brain regions, particularly 
thalamic, frontal, and subcortical, are associated with 
apathy. These findings suggest that the cortical-basal 
ganglia-thalamic circuits which have been implicated in 
the development of depression may also play a role in 
apathy. The ansalenticularis, which is the main output 
of the internal pallidum, occupies part of the posterior 
limb of the internal capsule [34]. This pathway projects 
to the pedunculopontine nucleus. This structure, 
located within the mesencephaliclocomotor region in 
cats and rodents, sends monosynaptic projections to 
motorneurons in the anterior horn and plays a 
prominent role in goal-oriented locomotorbehaviour 
[35]. 
Other lesion studies have identified apathy as 
occurring following damage to specific regions, for 
example, the ventromedial and dorsolateral prefrontal 
cortex [36]. 
It is perhaps predictable possibility that the more the 
lesion near or in the internal parts of the brain (where 
movements is also relevant there) the more likely there 
is apathy. But this is not exclusive. As such, frontal lobe 
and internal capsules and basal ganglia when effected 
patients are likely to show apathy. 
Neuropsychological Perspective 
Apathy may have a reciprocal interaction with the 
setting of the patients. Apathy is related to 
environmental, psychological, and neurobiological 
factors. Patients in nursing home units where more 
staff time is available for patient care has lower rates of 
apathy than patients on units with fewer and less 
available staff [37]. 
The magnitude of correlations between apathy and 
specific cognitive test scores varies significantly across 
studies, perhaps reflecting differences among studies 
in sample size, the range of cognitive and apathy 
scores in the sample, and the specific measure of 
apathy used. For example, in one study, two measures 
of apathy correlated significantly with the Mini Mental 
Status Examination (MMSE) (r=-.42 and r=-.32) while a 
third measure of apathy did not (r=-.06) [38]. 
Apathy is associated with impairment in both basic 
activities of daily living (ADLs; e.g. dressing, eating) 
and instrumental activities of daily living (IADLs; e.g., 
handling money, managing medications) [39]. 
Longitudinal and cross-sectional studies have 
identified a link between apathy and physical health. 
Apathy ratings obtained at admission to physical 
rehabilitation programs predict patient outcomes. 
Patients identified as apathetic at the start of a 
rehabilitation program are later rated as being less 
involved or active those programs [40]. These findings 
are likely consequence of their decreased involvement, 
those patients show less improvement compared to 
non-apathetic patients [41]. 
Patient apathy has been consistently related to 
caregiver burden, although the magnitude of this 
relationship has varied greatly across studies  
[e.g., 42-44]. 
In a meta-analysis of studies of stroke patients, the 
type of scale used moderated the prevalence estimate 
of apathy [1], where there is also a variation in 
prevalence, age and gender too. 
MEASURING APATHY 
Apathy Evaluation Scale 
Apathy Evaluation Scale is one of the often used 
measure in the field. The Apathy Evaluation Scale 
(AES) is an 18 item measure of apathy [45]. There are 
three versions of the AES: a self-report questionnaire 
version (AES-S), an informant-report questionnaire 
version (AES-I), and clinician-lead semi-structured 
interview version (AES-C). Marin and colleagues [45] 
labelled 6 items on the AES as cognitive (e.g. s/he is 
interested in things; getting things started on his/her 
own is important to him/her; s/he is interested in having 
new experiences), 5 items as behavioural (e.g. s/he 
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gets things done during the day; s/he puts little effort 
into anything; s/she spends time doing things that 
interest her/him), 2 items as emotional (i.e. s/he 
approaches life with intensity; when something good 
happens, s/he gets excited) and 3 items as “other” (i.e. 
s/he has an accurate understanding of her/his 
problems; s/he has initiative; s/he has motivation). The 
scales as such cover a range of impaired (negative) 
motivational aspects and self-awareness. 
Principal components analyses of the AES have 
consistently found evidence for a large general 
component, representing 30-50% of the scale variance 
[e.g., 46, 47]. This factor has been found in all versions 
of the AES [45] and in different patient groups (e.g. 
dementia, Clarke et al., 2007; first episode psychosis, 
[47]. This general component often includes items from 
each of the three diagnostic criteria for apathy: 
cognitive, behavioural, and emotional symptoms.  
Lille Apathy Ratings Scale (LARS) 
The Lille Apathy Rating Scale (LARS) was 
developed as a comprehensive measure of apathy 
[49]. The scale is based on a structured interview. It 
includes 33 items, divided into nine domains. 
Responses are scored on a dichotomous scale. It 
showed good ability to distinguish between depression 
and apathy. 
Other scale have been used for different reason but 
include apathy as subscales such as Neuropsychiatric 
Interview (NPI).The Neuropsychiatric Interview (NPI) 
was originally designed as a measure of psychopatho- 
logy for use in dementia patients [50]. 
The overall pictures addressed by scales 
(mentioned here or otherwise), seem to generate a 
clinical presentation of behavioural disorders in which a 
patient shows “negative symptoms” .i.e. reduction in 
motivation on a number of domains. This is clinically 
evident as well as in research; reduction in behaviour, 
and learning. 
Reduced motivation (in many domains) cause a 
burden for rehab team as well as caregivers. The fact 
that a patient with apathy shows reduction in 
engagement in rehabilitation and learning, is a problem 
in advancing their rehab progress [1, 2]. As a 
consequence this will increase the length of hospital 
stay as well impact the permanency of the CVA-related 
disability or impairments. Hence, any attention to 
apathy will improve the rehabilitation process as well as 
improve the quality of life for patients and caregivers. 
Not to mention the economic benefit from improving 
patients’ apathy. 
The treatment of apathy have shown to be 
interdisciplinary. Medications have a role to play but 
also the behavioural management. Pharmacological 
evidence is inconsistent and there are some case 
reports of benefiting from dopamine agonist [1], but 
much research needed. Behavioural approached with 
reinforcements techniques may also help, and control 
trials needed. All staff and caregiver have to detect 
apathy as early as possible and work on treating it, 
from early manifestation features. 
CONCLUSIONS 
Apathy is a common clinical disorder following 
stroke, and other neurological disorders and diseases. 
Apathy may have, nevertheless, been given less 
attention in clinical and research work. There is 
considerable evidence to show that many patients after 
stroke could show a form apathy in one stage or the 
other. This reported apathy is an independent of 
depression, which is also prevalent post stroke. Apathy 
is proposed here as (negative symptoms) following 
stroke; negative in the sense of being reduced level of 
motivation. It is manifested in a reduction in motivation 
in general, that can be seen in cognition, behaviour, or 
emotion. 
The nature of this negative clinical presentation is a 
factor in being ignored in clinical management. Since 
apathy does not effect staff or caregivers and it attracts 
less attention, unlike positive symptoms, such as angry 
reaction, aggression or crying and depression. It is also 
often misdiagnosed as depression, and treated as such 
with limited benefit. Apathy and depression can be 
comorbidity, but it argued here as independent 
symptoms and it is widely agreed now [1, 2]. This small 
commentary aimed to improve awareness. Apathy is a 
good predictor of outcome of rehabilitation. Apathy has 
to be evaluated and systematically assessed during 
initial admission and while the patients are undergoing 
a rehab programme. 
Rehabilitation of CVA has significant bearing on 
patients been actively engaged in rehab programme. 
Apathy, however, hinders such imperative process and 
may worsen patient’s dependency. This in turn 
prolonged the acquired impairments and limit the 
rehab. 
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Research is needed in areas of apathy 
measurement and appropriate clinical management. 
Any treatments will have significant impact on patients’ 
quality of life and progress, as well as reducing the 
burden of caregivers. Economic benefit in reduction in 
cost is also indicated as apathy is reduced. 
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